Open company graph database — free web & API
Login

Fukujyu Pharmaceutical Co., Ltd.

福寿製薬株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
101
Related companies
42
§01

Basic information

BASIC
Head office
48 Hagiwara, Toyama City, Toyama Prefecture, 939-8261Sources
Chief executive
Kozugi TeruoSources
Capital
60,000,000
Employees (non-consolidated)
100 people
Employees (consolidated)
101 people
Start date
1950-03-27
End date
§02

Websites

1 DOMAINS
§03

Business

9
Manufacturing and sale of pharmaceutical raw materials and intermediates for medical useSourcesManufacturing of raw materials and intermediates for clinical trial drugsSourcesContract synthesis of research chemicalsSourcesContract development of synthetic processesSourcesContract development of analytical testing methodsSourcesManufacturing of pharmaceutical raw materialsSourcesPowdering of pharmaceuticalsSourcesContract peptide synthesisSourcesContract flow synthesisSources
§04

Related companies

42 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Chugai Pharmaceutical Co., Ltd. SourcesSources
Customer Supplier
Fujifilm Toyama Chemical Co., Ltd. SourcesSources
Customer Supplier
Kaken Pharmaceutical Co., Ltd. SourcesSources
Customer Supplier
Kissei Pharmaceutical Industry Co., Ltd. SourcesSources
Customer Supplier
Kyorin Pharmaceutical Co., Ltd. SourcesSources
Customer Supplier
Nard Laboratory Inc. SourcesSources
Customer Supplier
Japan Shinyaku Co., Ltd. SourcesSources
Customer Supplier
ONO PHARMACEUTICAL CO., LTD. SourcesSources
Customer Supplier
Rohto Pharmaceutical Co., Ltd. SourcesSources
Customer Supplier
Spera Pharma Co., Ltd. SourcesSources
Customer Supplier
Sato Pharmaceutical SourcesSources
Customer Supplier
Chijuu Pharmaceutical Co., Ltd. SourcesSources
Customer Supplier
Shionogi & Co., Ltd. SourcesSources
Customer Supplier
Taisho Pharmaceutical Co., Ltd. SourcesSources
Customer Supplier
Tanabe Pharma Inc. SourcesSources
Customer Supplier
Takeda Pharmaceutical Company, Limited SourcesSources
Customer Supplier
DAIICHI SANKYO COMPANY, LIMITED SourcesSources
Customer Supplier
Asahi Kasei Pharma Corporation Sources
Customer
Astellas Pharma Inc. Sources
Customer
Eisai Co., Ltd. Sources
Customer
FUJI YAKUHIN CO., LTD. Sources
Customer
FUJIFILM Corporation Sources
Customer
Kowa Company, Ltd. Sources
Customer
Kyowa Kirin Co., Ltd. Sources
Customer
Mochida Pharmaceutical Co., LTD. Sources
Customer
Santen Pharmaceutical Co., Ltd. Sources
Customer
Sumitomo Pharma Co., Ltd. Sources
Customer
TAIHO PHARMACEUTICAL CO., LTD. Sources
Customer
Toray Industries, Inc. Sources
Customer
Astellas Pharma Inc. Sources
Supplier
Eisai Co., Ltd. Sources
Supplier
Sumitomo Pharma Co., Ltd. Sources
Supplier
Kyowa Kirin Co., Ltd. Sources
Supplier
Santan Pharmaceutical Co., Ltd. Sources
Supplier
Daipon Pharmaceutical Industries Co., Ltd. Sources
Supplier
Fuji Film Corporation Sources
Supplier
Mita Pharmaceutical Co., Ltd. Sources
Supplier
Asahi Kasei Pharma Corporation Sources
Supplier
Toray Industries, Inc. Sources
Supplier
Fuji Pharmaceutical Co., Ltd. Sources
Supplier
KYOKUTO KOWA CORPORATION Sources
Supplier
JUZEN Chemical Corporation Sources
Alliance
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

42 EVENTS

Founded (start of ointment production)Sources

Started ointment productionSources

Construction of Taro-maru factory (start of synthetic drug production)Sources

Started chemical synthesis of APISources

Headquarters relocation (Toyama City, Toyama Prefecture, Minamimachi → Nerima-ku, Tokyo)Sources

Relocated Head Office from Toyama to TokyoSources

Construction and relocation of Toyama factorySources

Completed Toyama plantSources

Construction of a formulation factory within the Toyama factorySources

Completed Formulation factory in Toyama plantSources

Headquarters relocation (Nerima-ku, Tokyo → Toyama City, Toyama Prefecture, Hagiwara)Sources

Headquarters relocated from Tokyo to ToyamaSources

Expansion of the formulation factorySources

Expansion of Formulation factorySources

Construction of the research institute and quality control department buildingSources

Completed R&D/QC buildingSources

Construction of four factories (clean rooms)Sources

The 4th production building with a clean room completed (or inaugurated)Sources

Construction of raw material and product warehouses, construction of the headquarters buildingSources

Completed Raw Material/Product Warehouse and Head OfficeSources

Renovation of the third drying room (clean room)Sources

Added a clean room to the 3rd Drying RoomSources

Constructed 5 factories (clean room)Sources

The 5th Plant with a clean room addedSources

Renovated the second drying roomSources

The 2nd Drying Room renovatedSources

Renovated the third drying room (clean room)Sources

Added a clean room to the 3nd Drying RoomSources

Renovated 6 factories (partial former formulation factory) (clean room/containment measures)Sources

Former formulation factory was renovated as the 6th plant having a containment facility and a clean roomSources

Established the Technology Development DepartmentSources

Established Technology Development & Research Dept.Sources

Established the Synthetic Research Department Root Scouting Group: Renovated 2 factories (introduced Hastelloy crucible)Sources

Newly established a Process Technology Research Group in Synthetic Chemistry Research Dept. : Added Hastelloy reactor to 2nd plantSources

Established the Business Planning Headquarters: Joined membership at Shonan Health Innovation ParkSources

Established Business Planning DivisionSources

Integrated Business Planning Headquarters into Management Headquarters: Started outsourced peptide synthesisSources

Business Planning Division integrated into Administration Division : Started contracted peptide synthesisSources

Renovated 1 factory: Established Safety Measures Group in the General Affairs DepartmentSources

The 1st Plant renovated : Established Safety Measures GroupSources

Established Audit Group in Management Headquarters: Constructed the Head Office buildingSources

Established Internal Audit Group : Completed Head office BuildingSources

§07

News

20 ARTICLES

Installation of Two New Reactors at Plant 2Sources

Fukuzyu Pharmaceutical Co., Ltd. announced the installation of two new reactors at Plant 2 on September 16, 2026. The update was posted on the company’s news release page. No additional details were provided in the brief notice.

Installation of two new reaction vessels at two plantsSources

Fukuju Pharmaceutical installed two new reaction vessels at two plants. The new reaction vessels feature high-heat-transfer glass on their inner surfaces, shortening heating and cooling times.

We Participated in the Corporate Relay Marathon in TOYAMA 2026!Sources

Fukujyu Pharmaceutical Co., Ltd. participated in the Corporate Relay Marathon held in Toyama on September 9, 2026.

Participated in the Corporate Exchange Relay MarathonSources

Employees of Fukuju Pharmaceutical participated in the Corporate Exchange Relay Marathon in TOYAMA 2026, held on September 6, 2026, at Toyama Sports Park.

Notice We held an open company eventSources

Notice We held an open company event

Notice Notice of Summer VacationSources

Notice Notice of Summer Vacation

Held an Online Open Company for 2028 GraduatesSources

On July 29, 2026, we held an online Open Company for university and graduate students graduating in 2028. Students interested in pharmaceutical companies participated.

Summer Holiday NoticeSources

Fukuju Pharmaceutical announces that its summer holiday will run from Saturday, August 8, 2026, to Sunday, August 16, 2026.

Notice Report on Our Exhibition at the ISPC 2026Sources

Notice Report on Our Exhibition at the ISPC 2026

Report on ISPC 2026 ExhibitionSources

Fukujyu Pharmaceutical exhibited at the 5th International Symposium on Process Chemistry (ISPC 2026) held from July 1 to 3, 2026.

§08

Public records

GOV
National Tax Agency basic information6230001002660
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
福寿製薬株式会社
Trade name (kana)
フクジュセイヤク
Name in English
Corporation type
301
Address
〒939-8261 富山県富山市萩原48番地
Postal code
9398261
Prefecture code
16
City code
201
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2022-07-01
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
3075807
METI gBizINFO6230001002660
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
6230001002660
Trade name
福寿製薬株式会社
Trade name (kana)
フクジュセイヤク
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
富山県富山市萩原48番地
Postal code
9398261
Prefecture
富山県
Prefecture code
16
City or district
富山市
City code
201
Street address
萩原48番地
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
Capital
Employees
99
Employees (male)
Employees (female)
Business summary
医薬品の製造販売(医療用医薬品原薬、治験用原薬、中間体)
Website URL
https://www.fkj.co.jp/
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2022-07-01
Key information
6230001002660
§09

Sources & updates

SOURCES
↑